Literature DB >> 18540633

The membrane proximal external region of the HIV-1 envelope glycoprotein gp41 contributes to the stabilization of the six-helix bundle formed with a matching N' peptide.

Eran Noah1, Zohar Biron, Fred Naider, Boris Arshava, Jacob Anglister.   

Abstract

The HIV-1 envelope glycoprotein gp41 undergoes a sequence of extensive conformational changes while participating in the fusion of the virus with the host cell. Since the discovery of its postfusion conformation, the structure and function of the protease-resistant six-helix bundle (6-HB) have been the subject of extensive investigation. In this work, we describe additional determinants (S528-Q540 and W666-N677) in the fusion peptide proximal region (FP-PR) and the membrane proximal external region (MPER) that stabilize the six-helix bundle and are involved in the interaction of T-20 (FUZEON, an anti-HIV-1 fusion inhibitor drug) with the gp41 FP-PR. Circular dichroism and sedimentation equilibrium measurements indicate that the 1:1 mixture of N' and C' peptides comprising residues A541-T569 and I635-K665 from the gp41 first and second helical repeats, HR1 and HR2, respectively, fail to form a stable six-helix bundle. Triglutamic acid and triarginine tags were added to these N' and C' peptides, respectively, at the termini distant from the FP-PR and the MPER to alter their pI and increase their solubility at pH 3.5. The tagged HR1 and HR2 peptides were elongated by addition of residues S528-Q540 from the FP-PR and residues W666-N677 from the MPER, respectively. A 1:1 complex of the elongated peptides formed a stable six-helix bundle which melted at 60 degrees C. These results underscore the importance of a detailed high-resolution characterization of MPER interactions, the results of which may improve our understanding of the structure-function relationship of gp41 and its role in HIV-1 fusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18540633      PMCID: PMC2459237          DOI: 10.1021/bi7023139

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  A monomeric 3(10)-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41.

Authors:  Zohar Biron; Sanjay Khare; Abraham O Samson; Yehezkiel Hayek; Fred Naider; Jacob Anglister
Journal:  Biochemistry       Date:  2002-10-22       Impact factor: 3.162

2.  US FDA approves new class of HIV therapeutics.

Authors:  Debra Robertson
Journal:  Nat Biotechnol       Date:  2003-05       Impact factor: 54.908

Review 3.  Protein stabilization by salt bridges: concepts, experimental approaches and clarification of some misunderstandings.

Authors:  Hans Rudolf Bosshard; Daniel N Marti; Ilian Jelesarov
Journal:  J Mol Recognit       Date:  2004 Jan-Feb       Impact factor: 2.137

4.  HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides.

Authors:  Shuwen Liu; Weiguo Jing; Byron Cheung; Hong Lu; Jane Sun; Xuxia Yan; Jinkui Niu; James Farmar; Shuguang Wu; Shibo Jiang
Journal:  J Biol Chem       Date:  2007-02-02       Impact factor: 5.157

5.  A template-assembled model of the N-peptide helix bundle from HIV-1 Gp-41 with high affinity for C-peptide.

Authors:  Weiming Xu; John W Taylor
Journal:  Chem Biol Drug Des       Date:  2007-10       Impact factor: 2.817

Review 6.  HIV entry inhibitors.

Authors:  José A Esté; Amalio Telenti
Journal:  Lancet       Date:  2007-07-07       Impact factor: 79.321

7.  Determination of equilibrium constants of associating protein systems. Graphical analysis for discrete and indefinite association.

Authors:  P W Chun; S J Kim
Journal:  Biochemistry       Date:  1970-04-28       Impact factor: 3.162

8.  Exploiting luminescence spectroscopy to elucidate the interaction between sugar and a tryptophan residue in the lactose permease of Escherichia coli.

Authors:  José Luis Vázquez-Ibar; Lan Guan; Maja Svrakic; H Ronald Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

9.  Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope.

Authors:  Gilad Ofek; Min Tang; Anna Sambor; Hermann Katinger; John R Mascola; Richard Wyatt; Peter D Kwong
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.

Authors:  G B Melikyan; R M Markosyan; H Hemmati; M K Delmedico; D M Lambert; F S Cohen
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  16 in total

1.  Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.

Authors:  Yael Wexler-Cohen; Avraham Ashkenazi; Mathias Viard; Robert Blumenthal; Yechiel Shai
Journal:  FASEB J       Date:  2010-07-06       Impact factor: 5.191

2.  Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface.

Authors:  Likai Song; Zhen-Yu J Sun; Kate E Coleman; Michael B Zwick; Johannes S Gach; Jia-huai Wang; Ellis L Reinherz; Gerhard Wagner; Mikyung Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-19       Impact factor: 11.205

3.  Immunization with hybrid proteins containing the membrane proximal external region of HIV-1.

Authors:  Nicola Strasz; Vladimir A Morozov; Jürgen Kreutzberger; Martina Keller; Magdalena Eschricht; Joachim Denner
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-07       Impact factor: 2.205

4.  Immunisation with foamy virus Bet fusion proteins as novel strategy for HIV-1 epitope delivery.

Authors:  Michael Mühle; Kerstin Hoffmann; Martin Löchelt; Joachim Denner
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

5.  Conformational properties of peptides corresponding to the ebolavirus GP2 membrane-proximal external region in the presence of micelle-forming surfactants and lipids.

Authors:  Lauren K Regula; Richard Harris; Fang Wang; Chelsea D Higgins; Jayne F Koellhoffer; Yue Zhao; Kartik Chandran; Jianmin Gao; Mark E Girvin; Jonathan R Lai
Journal:  Biochemistry       Date:  2013-05-07       Impact factor: 3.162

6.  The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.

Authors:  Adi Moseri; Zohar Biron; Boris Arshava; Tali Scherf; Fred Naider; Jacob Anglister
Journal:  FEBS J       Date:  2015-10-22       Impact factor: 5.542

Review 7.  Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.

Authors:  Hyun A Yi; Brian C Fochtman; Robert C Rizzo; Amy Jacobs
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

Review 8.  Immunising with the transmembrane envelope proteins of different retroviruses including HIV-1: a comparative study.

Authors:  Joachim Denner
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

9.  Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions.

Authors:  Victor Buzon; Ganesh Natrajan; David Schibli; Felix Campelo; Michael M Kozlov; Winfried Weissenhorn
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

Review 10.  Peptides in the treatment of AIDS.

Authors:  Fred Naider; Jacob Anglister
Journal:  Curr Opin Struct Biol       Date:  2009-07-23       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.